Form 4: Caleres Director Brenda Freeman Reports Acquisition of 12,131 Restricted Stock Units
Director Equity Grant
Caleres Inc. Director Brenda Freeman has reported the acquisition of 12,131 restricted stock units, contingent on her continued service through the next annual meeting of shareholders.
Summary
- Brenda Freeman, a Director of Caleres Inc. (CAL), acquired 12,131 Restricted Stock Units (RSUs).
- The transaction date for this acquisition was June 2, 2025.
- Each RSU represents a contingent right to receive the fair market value of one share of Caleres common stock.
- The fair market value per RSU at the time of acquisition was $13.19.
- Vesting of these RSUs is contingent upon Ms. Freeman's continued service as a director through the next annual meeting of shareholders.
- The RSUs will be settled in shares of common stock upon the termination of her service as a director or on another date she may elect.
- Following this transaction, Ms. Freeman beneficially owns 12,131 derivative securities in the form of Restricted Stock Units.
Sentiment
Score: 6
Explanation: The filing is a routine disclosure of an equity grant to a director, which is a neutral to slightly positive event as it aligns insider interests with shareholders. It contains no negative news or significant financial performance data.
Positives
- The acquisition of restricted stock units by a director aligns their interests with shareholders, as the value of the units is tied to the company's stock performance.
- The grant of RSUs as compensation is a common practice for retaining and incentivizing board members.
Negatives
- No specific negative information is disclosed in this Form 4 filing.
Risks
- The value of the restricted stock units is contingent on the fair market value of Caleres common stock, meaning their ultimate value to the director could fluctuate based on market performance.
- Vesting is contingent on continued service, meaning the director would forfeit the units if service terminates before the next annual meeting of shareholders.
Future Outlook
The vesting of the restricted stock units is contingent on Brenda Freeman's continued service as a director through the next annual meeting of shareholders, indicating a future milestone for the full realization of these units. The units will be settled in common stock upon termination of service or an elected date.
Management Comments
- No direct quotes or paraphrased statements from company management are included in this Form 4 filing, as it is a transactional disclosure.
Industry Context
This filing is a routine disclosure of an insider equity grant, common across publicly traded companies as part of director compensation packages. It does not provide broader industry trends or competitive analysis.
Comparison to Industry Standards
- The grant of restricted stock units (RSUs) to non-employee directors is a standard practice in corporate governance across various industries, including retail and footwear, to align director interests with long-term shareholder value.
- Companies like Nike (NKE), Skechers (SKX), and Crocs (CROX) also utilize equity-based compensation, including RSUs, for their directors and executives, reflecting a common approach to incentivize and retain talent.
- The specific number of units and their value ($13.19 per unit, totaling approximately $160,000 based on the transaction date price) would typically be benchmarked against peer companies of similar market capitalization and industry to ensure competitive compensation.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | NA | Brenda Freeman | NA | This filing reports an equity grant to an existing director, not a change in personnel. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy | The grant of restricted stock units to a director is part of the company's compensation policy for its board members, reflecting standard corporate governance practices related to director remuneration and alignment of interests. | 06/02/2025 | Aligns director incentives with long-term shareholder value by tying compensation to stock performance. |
Legal Proceedings
- No legal proceedings or regulatory matters are mentioned in this Form 4 filing.
Related Party Transactions
- The acquisition of restricted stock units by Brenda Freeman, a director, constitutes a transaction between the company and a related party (an insider). This is a standard form of compensation.
Stakeholder Impact
- Shareholders: The grant of RSUs to a director aligns their interests with shareholders, as the value of the compensation is tied to the company's stock performance.
- Employees: No direct impact on employees is indicated by this filing.
- Customers: No direct impact on customers is indicated by this filing.
- Suppliers: No direct impact on suppliers is indicated by this filing.
- Creditors: No direct impact on creditors is indicated by this filing.
Next Steps
- Brenda Freeman's continued service as a director through the next annual meeting of shareholders for the RSUs to vest.
- Settlement of the restricted stock units into shares of common stock upon termination of director service or an elected date.
Key Dates
| Date | Description |
|---|---|
| 06/02/2025 | Date of earliest transaction for the acquisition of Restricted Stock Units by Brenda Freeman. |
| 06/04/2025 | Date the Form 4 was signed by Thomas C. Burke, Attorney In Fact for Brenda Freeman. |
Recommendation
holdKeywords
Caleres Inc., CAL, SEC Form 4, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Grant, Beneficial Ownership, Brenda Freeman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.